[Therapy for patients with early-stage Parkinson's disease].
D000547:Amantadine / Q000008:administration & dosage; D000818:Animals; D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001971:Bromocriptine / Q000008:administration & dosage; D018491:Dopamine Agonists / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage; D010300:Parkinson Disease / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012642:Selegiline / Q000008:administration & dosage; D014282:Trihexyphenidyl / Q000008:administration & dosage
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D001971:Bromocriptine; D007980:Levodopa; D014282:Trihexyphenidyl; D000547:Amantadine